KIF2C and acute lymphoblastic leukemia: We analyzed the ability of KIF2C to serve as a therapeutic target of relapsed ALL and confirmed that KIF2C is highly induced in relapsed ALL patients; kif2c plays an important role in the homeostasis of HSCs through improvement of their survival.